Cogent Biosciences, Inc. (COGT) Capital expenditures 2017–2025
Cogent Biosciences, Inc. (COGT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.6MFY2025 · since FY2017: $912,000 → $1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6M | +171.2% |
| FY2024 | $573,000 | -79.5% |
| FY2023 | $2.8M | -59.3% |
| FY2022 | $6.9M | +299.2% |
| FY2021 | $1.7M | — |
| FY2019 | $33,000 | -94.0% |
| FY2018 | $549,000 | -39.8% |
| FY2017 | $912,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice